BME:DIA Statistics

Total Valuation

BME:DIA has a market cap or net worth of EUR 1.30 billion. The enterprise value is 1.95 billion.

Market Cap	1.30B
Enterprise Value	1.95B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:DIA has 58.06 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	58.06M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-1.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.30%
Float	12.94M

Valuation Ratios

The trailing PE ratio is 46.07 and the forward PE ratio is 24.02.

PE Ratio	46.07
Forward PE	24.02
PS Ratio	0.22
PB Ratio	-34.51
P/TBV Ratio	n/a
P/FCF Ratio	3.23
P/OCF Ratio	2.59
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.82, with an EV/FCF ratio of 4.85.

EV / Earnings	-24.80
EV / Sales	0.33
EV / EBITDA	5.82
EV / EBIT	41.26
EV / FCF	4.85

Financial Position

The company has a current ratio of 0.55

Current Ratio	0.55
Quick Ratio	0.34
Debt / Equity	n/a
Debt / EBITDA	2.94
Debt / FCF	2.45
Interest Coverage	0.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	1.20%
Return on Invested Capital (ROIC)	3.21%
Return on Capital Employed (ROCE)	5.53%
Revenue Per Employee	385,127
Profits Per Employee	-5,146
Employee Count	16,896
Asset Turnover	2.39
Inventory Turnover	15.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.70% in the last 52 weeks. The beta is 0.90, so BME:DIA's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	+69.70%
50-Day Moving Average	19.55
200-Day Moving Average	15.36
Relative Strength Index (RSI)	70.26
Average Volume (20 Days)	43,037

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:DIA had revenue of EUR 5.89 billion and -78.74 million in losses. Loss per share was -1.36.

Revenue	5.89B
Gross Profit	1.34B
Operating Income	47.40M
Pretax Income	37.84M
Net Income	-78.74M
EBITDA	179.98M
EBIT	47.40M
Loss Per Share	-1.36

Full Income Statement

Balance Sheet

The company has 333.47 million in cash and 985.49 million in debt, giving a net cash position of -652.03 million or -11.23 per share.

Cash & Cash Equivalents	333.47M
Total Debt	985.49M
Net Cash	-652.03M
Net Cash Per Share	-11.23
Equity (Book Value)	-37.68M
Book Value Per Share	-0.65
Working Capital	-655.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 502.28 million and capital expenditures -99.36 million, giving a free cash flow of 402.93 million.

Operating Cash Flow	502.28M
Capital Expenditures	-99.36M
Free Cash Flow	402.93M
FCF Per Share	6.94

Full Cash Flow Statement

Margins

Gross margin is 22.70%, with operating and profit margins of 0.80% and -1.34%.

Gross Margin	22.70%
Operating Margin	0.80%
Pretax Margin	0.64%
Profit Margin	-1.34%
EBITDA Margin	3.05%
EBIT Margin	0.80%
FCF Margin	6.84%

Dividends & Yields

BME:DIA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-6.05%
FCF Yield	30.98%

Stock Splits

The last stock split was on February 5, 2025. It was a reverse split with a ratio of 0.001.

Last Split Date	Feb 5, 2025
Split Type	Reverse
Split Ratio	0.001

Scores

BME:DIA has an Altman Z-Score of 2.43. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.43
Piotroski F-Score	n/a